NIH Looks to Uncover Connection Between Zika and HIV
As with other viruses, Zika may increase rates that infected mothers give HIV to their babies, despite medications.
Read More
Why Doctors Should Stop Writing Opioid Prescriptions by Hand
“We have a duty to practice in a way that has the lowest chance of harm to our patients.”
Abatacept Wins Its Third FDA Indication
The drug is now approved for psoriatic arthritis treatment in adults.
Anacetrapib Meets Primary Endpoint, But Its Future is Called Into Question
Despite its recent success, Morgan Stanley experts give the drug 5% odds of reaching markets.
Emicizumab Shows Strong Results in Phase III Hemophilia Trials
The drug met primary and secondary endpoints in both HAVEN 1 and HAVEN 2.
7 FDA Approvals You Need to Know
Plus a "Better Care Reconciliation Act" wrap up and 2 bonus approvals from across the pond.
AbbVie's Glacaprevir/Pibrentasvir Recommended for EMA Approval
The drug is an investigational treatment for adults with HCV.
Novartis' Canakinumab Meets Endpoint in Phase III CANTOS Trial
The drug reduced cardiovascular risk in people with prior heart attack and inflammatory atherosclerosis.
EMDAC Recommends Liraglutide's Approval to Reduce CV Risk in T2D Patients
Novo Nordisk seeks broad primary prevention claim, EMDAC recommends drug for patients with established CV.
Brolucizumab Meets Endpoints in Phase III Trials
The drug is comparable to aflibercept for nAMD, according to Novartis.
FDA Approves Delafloxacin for Bacterial Skin Infection Treatment
The drug is available for injection and in oral tablets.
FDA Accepts NDA for Fostamatinib Disodium
Manufacturer Rigel Pharmaceuticals expects an FDA decision by April, 2018.
FDA Approves Label Changes to HIV Drug
Lopinavir/ritonavir is not recommended for use with polyurethane feeding tubes.
Kausik Ray, MD, on the ODYSSEY Trial
Kausik Ray highlights the differences between the ODYSSEY DM-INSULIN trial differ from previous trials of PCSK9 inhibitors.
Cadazolid Gets Mixed Phase III Results as C. Difficile Treatment
The drug met endpoints of one phase III trial, but not another.
8 FDA Approvals You Need to Know About
The FDA had a busy week.
Consuming Diet Drinks During Pregnancy Increases Babies' Health Risks Long Term
Babies are larger at birth and twice as likely to be obese at age 7
FDA Approves Truvada Generic for HIV Treatment
2 generics are bioequivalent, therapeutically equivalent to Truvada.
FDA Requests First-Ever Removal of Painkiller from Market
Opana ER may be the first of many opioids to have approval revoked.
Upadacitinib Meets Primary, Secondary Endpoints for RA Treatment
The drug helped patients achieve clinical remission, low disease activity.
Even Low Levels of Alcohol Exposure Can Change Shape of Babies' Faces
Any amount of prenatal exposure can change development of nose, lips, eyes.
FDA Approves New Dosage for Schizophrenia Drug
Aripiprazole lauroxil now available in 2-month extended release dose.
FDA Expands Use for Transcatheter Heart Valve
85% of patients experienced improvement in heart failure symptoms
Macitentan Meets Primary, Secondary Endpoints in Phase II Trial
Originally approved for PAH, drug shows promise for CTEPH.
Diabetes Decreases Brain Cancer Risk
Glioma is less common among diabetes patients.
New Diabetic "Sugar Sponges" Could Replace Insulin Injections
Sugar Sponges could absorb and expel sugar in blood as needed.
Respiratory Failure Deadlier When It Happens in Hospitals
1 in 3 patients who get the condition in the hospital will die there.
FDA Approves New Once-Daily HIV Treatment
Isentress HD (raltegravir) is a new dosage of previously approved treatment.
Are Inhaled Statins a Viable Option for Asthmatics?
Simvastatin may reduce inflammation, fibrosis, bronchial constriction, mucus
What Is Asthma/COPD Overlap Syndrome?
Doctors need to conduct clinical trials and define the disease.